Assuntos
Antibacterianos , Farmacorresistência Bacteriana , Clima , Mudança Climática , Aquecimento Global , HumanosAssuntos
Infecções por Coronavirus/prevenção & controle , Regulamento Sanitário Internacional , Direito Internacional , Pandemias/prevenção & controle , Pneumonia Viral/prevenção & controle , Viagem/legislação & jurisprudência , COVID-19 , Infecções por Coronavirus/epidemiologia , Saúde Global/legislação & jurisprudência , Humanos , Pneumonia Viral/epidemiologia , Organização Mundial da SaúdeAssuntos
Infecções por Coronavirus/epidemiologia , Regulamento Sanitário Internacional/normas , Pneumonia Viral/epidemiologia , Betacoronavirus , COVID-19 , Infecções por Coronavirus/economia , Saúde Global , Humanos , Pandemias/economia , Pneumonia Viral/economia , Saúde Pública , SARS-CoV-2 , Organização Mundial da SaúdeAssuntos
Saúde Global/legislação & jurisprudência , Política de Saúde , Acessibilidade aos Serviços de Saúde/legislação & jurisprudência , Desenvolvimento Sustentável/legislação & jurisprudência , Feminino , Saúde Global/economia , Saúde Global/história , Equidade em Saúde/normas , Equidade em Saúde/tendências , Acessibilidade aos Serviços de Saúde/economia , Acessibilidade aos Serviços de Saúde/organização & administração , História do Século XXI , Humanos , Serviços Jurídicos/métodos , Expectativa de Vida/tendências , Masculino , Controle Social Formal/métodos , Pessoas Transgênero/legislação & jurisprudênciaRESUMO
The World Health Organization (WHO) was born as a normative agency and has looked to global health law to structure collective action to realize global health with justice. Framed by its constitutional authority to act as the directing and coordinating authority on international health, WHO has long been seen as the central actor in the development and implementation of global health law. However, WHO has faced challenges in advancing law to prevent disease and promote health over the past 75 years, with global health law constrained by new health actors, shifting normative frameworks, and soft law diplomacy. These challenges were exacerbated amid the COVID-19 pandemic, as states neglected international legal commitments in national health responses. Yet, global health law reforms are now underway to strengthen WHO governance, signaling a return to lawmaking for global health. Looking back on WHO's 75th anniversary, this article examines the central importance of global health law under WHO governance, reviewing the past successes, missed opportunities, and future hopes for WHO. For WHO to meet its constitutional authority to become the normative agency it was born to be, we offer five proposals to reestablish a WHO fit for purpose: normative instruments, equity and human rights mainstreaming, sustainable financing, One Health, and good governance. Drawing from past struggles, these reforms will require further efforts to revitalize hard law authorities in global health, strengthen WHO leadership across the global governance landscape, uphold equity and rights at the center of global health law, and expand negotiations in global health diplomacy.
RESUMO
Negotiations ought not focus on enforcement and sanctions.
Assuntos
Cooperação Internacional , Direito Internacional , Pandemias , Pandemias/legislação & jurisprudência , Pandemias/prevenção & controle , Cooperação Internacional/legislação & jurisprudência , Organização Mundial da Saúde , HumanosRESUMO
The COVID-19 pandemic has shown the need for better global governance of pandemic prevention, preparedness, and response (PPR) and has emphasised the importance of organised knowledge production and uptake. In this Health Policy, we assess the potential values and risks of establishing an Intergovernmental Panel for One Health (IPOH). Similar to the Intergovernmental Panel on Climate Change, an IPOH would facilitate knowledge uptake in policy making via a multisectoral approach, and hence support the addressing of infectious disease emergence and re-emergence at the human-animal-environment interface. The potential benefits to pandemic PPR include a clear, unified, and authoritative voice from the scientific community, support to help donors and institutions to prioritise their investments, evidence-based policies for implementation, and guidance on defragmenting the global health system. Potential risks include a scope not encompassing all pandemic origins, unclear efficacy in fostering knowledge uptake by policy makers, potentially inadequate speed in facilitating response efforts, and coordination challenges among an already dense set of stakeholders. We recommend weighing these factors when designing institutional reforms for a more effective global health system.